Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Eckhardt

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|November 1, 1988
Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogenJ I Weitz, M K Cruickshank, B Thong, et al.
Developments in Biological Standardization|January 1, 1997
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupS Schmitt-Grohé, K Stehr, J D Cherry, et al.
European Journal of Cancer Care|June 4, 2009
Quality of life and adjuvant tamoxifen treatment in breast cancer patientsDaniel Ulrich Boehm, A Lebrecht, T Eckhardt, et al.
Journal of Bacteriology|September 1, 1988
Secretion of interleukin-1 beta and Escherichia coli galactokinase by Streptomyces lividansH Lichenstein, M E Brawner, L M Miles, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 4, 1999
Viability and recovery of frozen-thawed human islets and in vivo quality control by xenotransplantationS Langer, D Lau, T Eckhardt, et al.
Pediatrics|September 17, 1998
Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study GroupU Heininger, J D Cherry, K Stehr, et al.
Pediatrics|January 17, 1998
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccineK Stehr, J D Cherry, U Heininger, et al.
Vaccine|January 1, 1994
Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in GermanyU Heininger, J D Cherry, P D Christenson, et al.
Infection and Immunity|May 1, 1993
Biochemical and immunological properties of two forms of pertactin, the 69,000-molecular-weight outer membrane protein of Bordetella pertussisJ W Gotto, T Eckhardt, P A Reilly, et al.
Zentralblatt Fur Chirurgie|September 25, 1998
[Graft rejection in experimental xenogenic transplantation of isolated islands of Langerhans of the pig]H Jahr, D Brandhorst, H Brandhorst, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|November 1, 1988
Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogenJ I Weitz, M K Cruickshank, B Thong, et al.
Developments in Biological Standardization|January 1, 1997
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupS Schmitt-Grohé, K Stehr, J D Cherry, et al.
European Journal of Cancer Care|June 4, 2009
Quality of life and adjuvant tamoxifen treatment in breast cancer patientsDaniel Ulrich Boehm, A Lebrecht, T Eckhardt, et al.
Journal of Bacteriology|September 1, 1988
Secretion of interleukin-1 beta and Escherichia coli galactokinase by Streptomyces lividansH Lichenstein, M E Brawner, L M Miles, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 4, 1999
Viability and recovery of frozen-thawed human islets and in vivo quality control by xenotransplantationS Langer, D Lau, T Eckhardt, et al.
Pediatrics|September 17, 1998
Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study GroupU Heininger, J D Cherry, K Stehr, et al.
Pediatrics|January 17, 1998
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccineK Stehr, J D Cherry, U Heininger, et al.
Vaccine|January 1, 1994
Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in GermanyU Heininger, J D Cherry, P D Christenson, et al.
Infection and Immunity|May 1, 1993
Biochemical and immunological properties of two forms of pertactin, the 69,000-molecular-weight outer membrane protein of Bordetella pertussisJ W Gotto, T Eckhardt, P A Reilly, et al.
Zentralblatt Fur Chirurgie|September 25, 1998
[Graft rejection in experimental xenogenic transplantation of isolated islands of Langerhans of the pig]H Jahr, D Brandhorst, H Brandhorst, et al.
Pageof 4